275 related articles for article (PubMed ID: 8938167)
1. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?
Robert A; Chazouillères O
Hepatology; 1996 Dec; 24(6):1392-4. PubMed ID: 8938167
[TBL] [Abstract][Full Text] [Related]
2. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology.
Bellest L; Eschwège V; Poupon R; Chazouillères O; Robert A
Hepatology; 2007 Aug; 46(2):528-34. PubMed ID: 17654598
[TBL] [Abstract][Full Text] [Related]
3. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
van den Besselaar AM
J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
[TBL] [Abstract][Full Text] [Related]
4. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
[TBL] [Abstract][Full Text] [Related]
5. [A discussion of standardization for prothrombin time in patients with advanced liver diseases].
Li Q; Cong YL; Wang BE; Jia JD; Chen Y; Zhang FK; Ou XJ; Wei YX; Ma H
Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):128-31. PubMed ID: 15727702
[TBL] [Abstract][Full Text] [Related]
6. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
7. [Prothrombin time and its standardization].
Kagawa K
Rinsho Byori; 2002 Aug; 50(8):779-85. PubMed ID: 12373814
[TBL] [Abstract][Full Text] [Related]
8. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
Gouin I; Horellou MH; Conard J; Samama M
Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results--the Bologna oral anticoagulant control exercise.
Palareti G; Coccheri S; Poggi M; Bonetti M; Cervi V; Mazzuca A; Savoia M; Veri L; Fiori F; Gaspari G
Thromb Haemost; 1987 Oct; 58(3):905-10. PubMed ID: 3433253
[TBL] [Abstract][Full Text] [Related]
10. [Obtaining a reference pattern of rabbit brain thromboplastin].
Martínez Placencia BM; Lanzetti Theiler MC; Córdova Caballero MS
Rev Invest Clin; 1989; 41(3):247-52. PubMed ID: 2813999
[TBL] [Abstract][Full Text] [Related]
11. French multicentric evaluation of recombinant tissue factor (recombiplastin) for determination of prothrombin time.
Roussi J; Drouet L; Samama M; Sié P
Thromb Haemost; 1994 Nov; 72(5):698-704. PubMed ID: 7900077
[TBL] [Abstract][Full Text] [Related]
12. [Quality control of ISI/INR system in oral anticoagulant therapy].
Kazama M
Rinsho Ketsueki; 1990 Jun; 31(6):769-75. PubMed ID: 2214167
[TBL] [Abstract][Full Text] [Related]
13. Implications of use of low international sensitivity index thromboplastins in prothrombin time testing.
Ts'ao C; Swedlund J; Neofotistos D
Arch Pathol Lab Med; 1994 Dec; 118(12):1183-7. PubMed ID: 7979911
[TBL] [Abstract][Full Text] [Related]
14. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
Horsti J
Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
[TBL] [Abstract][Full Text] [Related]
15. [Control of oral anticoagulation. Current concepts].
Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
[TBL] [Abstract][Full Text] [Related]
16. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of international normalized ratios by a controlled field survey with 4 different thromboplastin reagents.
Kazama M; Suzuki S; Abe T; Tahara C; Shimazu C; Akiyama Y; Higashi K; Ishiguro I; Kimura T; Motoi S
Thromb Haemost; 1990 Dec; 64(4):535-41. PubMed ID: 2084938
[TBL] [Abstract][Full Text] [Related]
18. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
[TBL] [Abstract][Full Text] [Related]
19. ISI/INR system in Japan: experience from simultaneous measurement of the same plasma at four different laboratories.
Uetsuka Y; Sakuragawa N; Wada H; Aizawa Y; Aosaki M
Semin Thromb Hemost; 2000; 26(1):109-12. PubMed ID: 10805291
[TBL] [Abstract][Full Text] [Related]
20. Standardizing the prothrombin time. Calibrating coagulation instruments as well as thromboplastin.
Becker DM; Humphries JE; Walker FB; DeMong LK; Bopp JS; Acker MN
Arch Pathol Lab Med; 1993 Jun; 117(6):602-5. PubMed ID: 8503731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]